immatics biotechnologies GmbH
Utility Patent Applications

Last updated:

List of all immatics biotechnologies GmbH patents 454 in total

Status Patent
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) External link
Filling date: 9 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: RELAXIN1 DERIVED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: METHOD FOR HIGH THROUGHPUT PEPTIDE-MHC AFFINITY SCREENING FOR TCR LIGANDS External link
Filling date: 9 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN External link
Filling date: 9 Sep 2025 Issue date: 12 Mar 2020
Application
Utility: UTERINE CANCER TREATMENTS External link
Filling date: 9 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS External link
Filling date: 9 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 9 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 9 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 20 Feb 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 9 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 9 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC External link
Filling date: 9 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 12 Dec 2019

Showing 350 to 400 of 454 patents.